Norbert Hoefgen

Title: Norbert Hoefgen: Innovator in Pharmaceutical Chemistry

Introduction

Norbert Hoefgen is a notable inventor based in Ottendorf-Okrilla, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific diseases.

Latest Patents

One of his key inventions is a patent for (1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases. This invention relates to compounds that inhibit phosphodiesterase 2 and/or 10, which are useful in treating central nervous system diseases. His innovative approach has the potential to impact therapeutic strategies for various neurological conditions.

Career Highlights

Norbert Hoefgen is currently associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at this esteemed organization has allowed him to focus on research and development in the pharmaceutical sector, contributing to advancements in drug discovery and development.

Collaborations

He has collaborated with notable colleagues, including Hans-Joachim Lankau and Barbara Langen. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Norbert Hoefgen's contributions to pharmaceutical chemistry, particularly through his patent on (1,2,4)triazolo[4,3-A]quinoxaline derivatives, highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in treating central nervous system diseases.